717 top medical experts on Multiple Sclerosis across 52 countries and 39 U.S. states, including 662 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Multiple Sclerosis: An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see multiple sclerosis, relapsing-remitting), but acute fulminating and chronic progressive forms (see multiple sclerosis, chronic progressive) also occur. (Adams et al., Principles of Neurology, 6th ed, p903)
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Broader Categories (#Experts): CNS Demyelinating Autoimmune Diseases (588) and Narrower Categories: Chronic Progressive Multiple Sclerosis (814), Relapsing-Remitting Multiple Sclerosis (2,245).
  4. Clinical Trials ClinicalTrials.gov : at least 1,822 including 91 Active, 994 Completed, 305 Recruiting
  5. Synonyms: MS (Multiple Sclerosis), Acute Fulminating Multiple Sclerosis, Disseminated Sclerosis


  

        

                    


    Computing Expert Listing ...

);